跳至主要内容
临床试验/IRCT20240613062116N1
IRCT20240613062116N1尚未招募3 期

Investigating the effect of Mebourein drug on the clinical symptoms of patients with slow coronary flow

Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Performing diagnostic angiography due to chronic symptoms or positive non-invasive test
  • TIMI frame count greater than 27 in angiography
  • In the injection of angiography contrast material, after 3 heartbeats, the contrast material has not reached the end of the coronary arteries in patients.

排除标准

  • Non-satisfaction or non-cooperation in taking Mebourein or placebo
  • Failure to visit the heart clinic regularly within 1 month of angiography
  • History of heart failure in echocardiography
  • Any patient who has a history of valvular disease or any other heart disease
  • Patients who experience acute coronary events during this period
  • Patients with vascular ectasia
  • Involvement of more than 50% of epicardial vessels

研究者

相似试验